SEC 13F Intelligence

Rhenman & Partners Asset Management AB / ELV

Rhenman & Partners Asset Management AB’s Elevance Health Inc Formerly Position

Does Rhenman & Partners Asset Management AB own Elevance Health Inc Formerly (ELV)? Yes — 32.3K shares worth $9M (+1.17% of its 13F portfolio) as of Q1 2026, up from 15.0K shares the prior filed quarter.

Position Value
$9M
Q1 2026
Shares
32.3K
% of Portfolio
+1.17%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $21MQ4 ’18Q1 ’19: $21MQ2 ’19: $25MQ3 ’19: $14MQ4 ’19: $19MQ4 ’19Q1 ’20: $15MQ2 ’20: $17MQ3 ’20: $24MQ4 ’20: $26MQ4 ’20Q1 ’21: $34MQ2 ’21: $36MQ3 ’21: $45MQ4 ’21: $46MQ4 ’21Q1 ’22: $23MQ2 ’22: $28MQ3 ’22: $22MQ4 ’22: $23MQ4 ’22Q1 ’23: $26MQ2 ’23: $25MQ3 ’23: $17MQ4 ’23: $6MQ4 ’23Q1 ’24: $36MQ2 ’24: $46MQ3 ’24: $26MQ4 ’24: $9MQ4 ’24Q1 ’25: $21MQ2 ’25: $17MQ3 ’25: $7MQ4 ’25: $5MQ4 ’25Q1 ’26: $9Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202632.3K$9M+1.17%
Q4 202515.0K$5M+0.49%
Q3 202522.5K$7M+0.80%
Q2 202544.6K$17M+2.20%
Q1 202549.0K$21M+2.45%
Q4 202423.1K$9M+0.88%
Q3 202450.5K$26M+2.13%
Q2 202485.8K$46M+4.46%
Q1 202469.5K$36M+3.42%
Q4 202313.0K$6M+0.61%
Q3 202338.0K$17M+1.78%
Q2 202356.0K$25M+2.62%
Q1 202356.0K$26M+2.82%
Q4 202245.0K$23M+2.41%
Q3 202240.0K$22M+2.29%
Q2 202257.0K$28M+3.13%
Q1 202246.2K$23M+2.24%
Q4 202198.0K$46M+3.04%
Q3 2021120.0K$45M+3.14%
Q2 202195.0K$36M+2.46%
Q1 202195.0K$34M+2.38%
Q4 202080.0K$26M+2.10%
Q3 202090.0K$24M+2.15%
Q2 202065.0K$17M+1.85%
Q1 202065.0K$15M+2.07%
Q4 201962.0K$19M+2.05%
Q3 201960.0K$14M+1.81%
Q2 201990.0K$25M+2.80%
Q1 201973.6K$21M+2.47%
Q4 201878.6K$21M+2.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of ELV.